Chronic inflammatory bowel disease (CIBD) refers to long-term inflammation of the gastrointestinal tract, chiefly Crohn’s disease and ulcerative colitis. It causes abdominal pain, diarrhea, rectal bleeding, weight loss and fatigue. Causes involve immune system dysregulation, genetic predisposition and environmental triggers. Management includes anti-inflammatory and immunosuppressive medications, biologic therapies, dietary measures, and sometimes surgery to control inflammation and complications.

An IBD profile blood test is a panel used to detect and monitor inflammatory bowel disease activity. It typically includes markers of inflammation (CRP, ESR), a complete blood count to assess anemia, albumin and liver tests for nutrition and complications, and serologic markers (pANCA, ASCA) that may help differentiate ulcerative colitis from Crohn’s. Results support diagnosis and guide treatment alongside clinical assessment and imaging.

Chronic inflammatory bowel disease (CIBD), which includes Crohn’s disease and ulcerative colitis, is generally not curable. Treatment focuses on inducing and maintaining remission with medications, diet and lifestyle changes; surgery can remove the diseased colon and may cure ulcerative colitis but not Crohn’s. Long-term management aims to control inflammation, prevent complications and improve quality of life.

Yes. CIDP is a serious, chronic autoimmune disorder that damages peripheral nerves, causing progressive weakness, numbness, and impaired coordination. Without treatment it can lead to significant disability and reduced quality of life; respiratory or swallowing muscle involvement is uncommon but possible. Early diagnosis and immune-modulating treatments (steroids, IVIG, plasmapheresis, immunosuppressants) often improve outcomes, though relapses or residual deficits can occur.

Doctors confirm inflammatory bowel disease (IBD) through medical history and physical exam, blood tests (CBC, CRP/ESR), and stool tests (calprotectin) to detect inflammation. Colonoscopy with biopsy is the diagnostic gold standard; biopsy distinguishes Crohn’s disease from ulcerative colitis. Imaging — CT or MR enterography — or capsule endoscopy assess small-bowel involvement. Tests are combined to establish diagnosis and extent of disease.

Irritable bowel syndrome (IBS) is usually a long-term condition for many people, characterized by recurring abdominal pain and bowel habit changes that can wax and wane. There’s no universal cure, but symptoms often improve or enter long periods of remission with dietary changes, stress management and treatments. Some people experience complete symptom resolution, while others need ongoing management to control flare-ups.